The KNOP1 Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat T-lymphocyte line, designed to disrupt the KNOP1 gene. This heterogeneous pool of edited cells enables researchers to study the functional consequences of KNOP1 loss without clonal selection artifacts, preserving the genetic diversity of the edited population for robust downstream analyses. The CRISPR/Cas9-mediated gene disruption creates a loss-of-function model that allows interrogation of KNOP1??s role in ribosome biogenesis and T-cell biology.
The Jurkat host cell line is an immortalized human T lymphocyte line originally derived from the peripheral blood of an acute T-cell leukemia patient. It serves as a widely used model for investigating T-cell signaling, activation, and apoptosis, as well as the molecular mechanisms underlying T-cell acute lymphoblastic leukemia (T-ALL). Jurkat cells are characterized by rapid proliferation and stable growth in suspension culture, making them well-suited for high-throughput functional genomics studies. This background provides a clinically relevant context to explore how nucleolar protein dysfunction contributes to leukemogenesis.
KNOP1 is a nucleolar protein that functions as a critical regulator of ribosome biogenesis, specifically participating in the processing of precursor ribosomal RNA (pre-rRNA). It acts downstream of major growth signaling pathways: transcriptionally controlled by MYC and activated by mTORC1, thus integrating nutrient and growth signals with ribosome production. KNOP1 interacts with nucleolar factors NOP2 and nucleolin, and collaborates with the RNA polymerase I transcription machinery??including UBF, SL1, and TTF-I??as well as small nucleolar ribonucleoproteins (snoRNPs) and fibrillarin to orchestrate pre-rRNA cleavage and ribosomal subunit assembly. Disruption of KNOP1 is anticipated to impair these processes, leading to defective ribosome maturation and diminished protein synthesis capacity.
In the Jurkat T-ALL model, elevated ribosome biogenesis demands render cells particularly sensitive to KNOP1 loss. Knockout of KNOP1 may compromise ribosome production, thereby attenuating proliferation and sensitizing leukemic cells to apoptotic stimuli. This model offers a valuable tool to dissect how nucleolar stress intersects with oncogenic signaling pathways driven by MYC and mTORC1 in T-cell malignancies. Moreover, it enables examination of feedback between ribosome biogenesis and cell cycle progression in a leukemia context.
Researchers can employ this polyclonal knockout population in diverse assays to dissect KNOP1 biology. Western blotting and RT-qPCR can confirm gene disruption and monitor expression of ribosome biogenesis factors. rRNA processing analysis and cell proliferation assays allow direct assessment of defects in ribosome assembly and growth. Flow cytometry and apoptosis assays facilitate studies of cell cycle perturbations and programmed cell death. Additionally, the model is suitable for drug target validation, screening compounds that synergize with impaired ribosome biogenesis to eliminate leukemia cells. For further technical details or ordering information, please contact Ascent Research.
